The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, Y.
Right arrow Articles by Matis, L. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, Y.
Right arrow Articles by Matis, L. A.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
Medline Plus Health Information
*Joint Disorders
The Journal of Immunology, 2000, 164: 4340-4347.
Copyright © 2000 by The American Association of Immunologists

A Role for Complement in Antibody-Mediated Inflammation: C5-Deficient DBA/1 Mice Are Resistant to Collagen-Induced Arthritis

Yi Wang1,*, Jane Kristan*, Liming Hao{dagger}, Catherine S. Lenkoski*, Yamin Shen* and Louis A. Matis1,*

* Alexion Pharmaceuticals, Inc., New Haven, CT 06511; and {dagger} Department of Pathology, Yale University School of Medicine, New Haven, CT 06520

Collagen-induced arthritis (CIA) represents an animal model of autoimmune polyarthritis with significant similarities to human rheumatoid arthritis that can be induced upon immunization with native type II collagen. As in rheumatoid arthritis, both cellular and humoral immune mechanisms contribute to disease pathogenesis. Genotypic studies have identified at least six genetic loci contributing to arthritis susceptibility, including the class II MHC. We have examined the mechanism of Ab-mediated inflammation in CIA joints, specifically the role of complement activation, by deriving a line of mice from the highly CIA-susceptible DBA/1LacJ strain that are congenic for deficiency of the C5 complement component. We show that such C5-deficient DBA/1LacJ animals mount normal cellular and humoral immune responses to native type II collagen, with the activation of collagen-specific TNF-{alpha}-producing T cells in the periphery and substantial intra-articular deposition of complement-fixing IgG Abs. Nevertheless, these C5-deficient mice are highly resistant to the induction of CIA. These data provide evidence for an important role of complement in Ab-triggered inflammation and in the pathogenesis of autoimmune arthritis.




This article has been cited by other articles:


Home page
J. Immunol.Home page
N. K. Banda, B. Levitt, M. J. Glogowska, J. M. Thurman, K. Takahashi, G. L. Stahl, S. Tomlinson, W. P. Arend, and V. M. Holers
Targeted Inhibition of the Complement Alternative Pathway with Complement Receptor 2 and Factor H Attenuates Collagen Antibody-Induced Arthritis in Mice
J. Immunol., November 1, 2009; 183(9): 5928 - 5937.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
H Mbarek, M Kallel-Sellami, Y Zerzri, K Dawidowicz, K Mejri, T Bardin, B Prum, P Dieude, E Petit-Teixeira, F Cornelis, et al.
New rheumatoid arthritis genetic factor and C5 serum level
Ann Rheum Dis, September 1, 2009; 68(9): 1508 - 1509.
[Full Text] [PDF]


Home page
FASEB J.Home page
K. E. Nilsson, M. Andren, T. D. de Stahl, and S. Kleinau
Enhanced susceptibility to low-dose collagen-induced arthritis in CR1/2-deficient female mice--possible role of estrogen on CR1 expression
FASEB J, August 1, 2009; 23(8): 2450 - 2458.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. L. Ellsworth, N. Hamacher, B. Harder, K. Bannink, T. R. Bukowski, K. Byrnes-Blake, S. Underwood, C. Oliver, K. S. Waggie, C. Noriega, et al.
Recombinant Soluble Human Fc{gamma}R1A (CD64A) Reduces Inflammation in Murine Collagen-Induced Arthritis
J. Immunol., June 1, 2009; 182(11): 7272 - 7279.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. E. Happonen, A. P. Sjoberg, M. Morgelin, D. Heinegard, and A. M. Blom
Complement Inhibitor C4b-Binding Protein Interacts Directly with Small Glycoproteins of the Extracellular Matrix
J. Immunol., February 1, 2009; 182(3): 1518 - 1525.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Song, F. Qiao, C. Atkinson, V. M. Holers, and S. Tomlinson
A Complement C3 Inhibitor Specifically Targeted to Sites of Complement Activation Effectively Ameliorates Collagen-Induced Arthritis in DBA/1J Mice
J. Immunol., December 1, 2007; 179(11): 7860 - 7867.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
C. E. Vergunst, D. M. Gerlag, H. Dinant, L. Schulz, M. Vinkenoog, T. J. M. Smeets, M. E. Sanders, K. A. Reedquist, and P. P. Tak
Blocking the receptor for C5a in patients with rheumatoid arthritis does not reduce synovial inflammation
Rheumatology, December 1, 2007; 46(12): 1773 - 1778.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
R. M. Plenge, M. Seielstad, L. Padyukov, A. T. Lee, E. F. Remmers, B. Ding, A. Liew, H. Khalili, A. Chandrasekaran, L. R.L. Davies, et al.
TRAF1-C5 as a Risk Locus for Rheumatoid Arthritis -- A Genomewide Study
N. Engl. J. Med., September 20, 2007; 357(12): 1199 - 1209.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
X. Yu, K. Bauer, P. Wernhoff, D. Koczan, S. Moller, H.-J. Thiesen, and S. M. Ibrahim
Fine Mapping of Collagen-Induced Arthritis Quantitative Trait Loci in an Advanced Intercross Line
J. Immunol., November 15, 2006; 177(10): 7042 - 7049.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. M. Fusello, L. Mandik-Nayak, F. Shih, R. E. Lewis, P. M. Allen, and A. S. Shaw
The MAPK Scaffold Kinase Suppressor of Ras Is Involved in ERK Activation by Stress and Proinflammatory Cytokines and Induction of Arthritis
J. Immunol., November 1, 2006; 177(9): 6152 - 6158.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A.-K. B. Lindqvist, M. Johannesson, A. C. M. Johansson, K. S. Nandakumar, A. M. Blom, and R. Holmdahl
Backcross and Partial Advanced Intercross Analysis of Nonobese Diabetic Gene-Mediated Effects on Collagen-Induced Arthritis Reveals an Interactive Effect by Two Major Loci
J. Immunol., September 15, 2006; 177(6): 3952 - 3959.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
T. Honda, E. Segi-Nishida, Y. Miyachi, and S. Narumiya
Prostacyclin-IP signaling and prostaglandin E2-EP2/EP4 signaling both mediate joint inflammation in mouse collagen-induced arthritis
J. Exp. Med., February 21, 2006; 203(2): 325 - 335.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Sjoberg, P. Onnerfjord, M. Morgelin, D. Heinegard, and A. M. Blom
The Extracellular Matrix and Inflammation: FIBROMODULIN ACTIVATES THE CLASSICAL PATHWAY OF COMPLEMENT BY DIRECTLY BINDING C1q
J. Biol. Chem., September 16, 2005; 280(37): 32301 - 32308.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
E.-K. Lee, S.-M. Kang, D.-J. Paik, J. M. Kim, and J. Youn
Essential roles of Toll-like receptor-4 signaling in arthritis induced by type II collagen antibody and LPS
Int. Immunol., March 1, 2005; 17(3): 325 - 333.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. O. Judex and B. M. Mueller
Plasminogen Activation/Plasmin in Rheumatoid Arthritis: Matrix Degradation and More
Am. J. Pathol., March 1, 2005; 166(3): 645 - 647.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. Li, A. Ny, G. Leonardsson, K. S. Nandakumar, R. Holmdahl, and T. Ny
The Plasminogen Activator/Plasmin System Is Essential for Development of the Joint Inflammatory Phase of Collagen Type II-Induced Arthritis
Am. J. Pathol., March 1, 2005; 166(3): 783 - 792.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A.-S. Hansson, M. Johannesson, L. Svensson, K. S. Nandakumar, D. Heinegard, and R. Holmdahl
Relapsing Polychondritis, Induced in Mice with Matrilin 1, Is an Antibody- and Complement-Dependent Disease
Am. J. Pathol., March 1, 2004; 164(3): 959 - 966.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. A. Latham, A. Zamora, H. Drought, S. Subramanian, A. Matejuk, H. Offner, and E. F. Rosloniec
Estradiol Treatment Redirects the Isotype of the Autoantibody Response and Prevents the Development of Autoimmune Arthritis
J. Immunol., December 1, 2003; 171(11): 5820 - 5827.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Szczepanik, M. Akahira-Azuma, K. Bryniarski, R. F. Tsuji, I. Kawikova, W. Ptak, C. Kiener, R. A. Campos, and P. W. Askenase
B-1 B Cells Mediate Required Early T Cell Recruitment to Elicit Protein-Induced Delayed-Type Hypersensitivity
J. Immunol., December 1, 2003; 171(11): 6225 - 6235.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
K. S. Nandakumar, L. Svensson, and R. Holmdahl
Collagen Type II-Specific Monoclonal Antibody-Induced Arthritis in Mice: Description of the Disease and the Influence of Age, Sex, and Genes
Am. J. Pathol., November 1, 2003; 163(5): 1827 - 1837.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
P. W. Askenase
Mast Cells and the Mediation of T-Cell Recruitment in Arthritis
N. Engl. J. Med., September 25, 2003; 349(13): 1294 - 1294.
[Full Text] [PDF]


Home page
J. Immunol.Home page
N. K. Banda, D. M. Kraus, M. Muggli, A. Bendele, V. M. Holers, and W. P. Arend
Prevention of Collagen-Induced Arthritis in Mice Transgenic for the Complement Inhibitor Complement Receptor 1-Related Gene/Protein y
J. Immunol., August 15, 2003; 171(4): 2109 - 2115.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. A. Fava, E. Notidis, J. Hunt, V. Szanya, N. Ratcliffe, A. Ngam-ek, A. R. de Fougerolles, A. Sprague, and J. L. Browning
A Role for the Lymphotoxin/LIGHT Axis in the Pathogenesis of Murine Collagen-Induced Arthritis
J. Immunol., July 1, 2003; 171(1): 115 - 126.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Kagari, D. Tanaka, H. Doi, and T. Shimozato
Essential Role of Fc{gamma} Receptors in Anti-Type II Collagen Antibody-Induced Arthritis
J. Immunol., April 15, 2003; 170(8): 4318 - 4324.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
E. P. Grant, D. Picarella, T. Burwell, T. Delaney, A. Croci, N. Avitahl, A. A. Humbles, J.-C. Gutierrez-Ramos, M. Briskin, C. Gerard, et al.
Essential Role for the C5a Receptor in Regulating the Effector Phase of Synovial Infiltration and Joint Destruction in Experimental Arthritis
J. Exp. Med., December 2, 2002; 196(11): 1461 - 1471.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
R. F. Tsuji, M. Szczepanik, I. Kawikova, V. Paliwal, R. A. Campos, A. Itakura, M. Akahira-Azuma, N. Baumgarth, L. A. Herzenberg, and P. W. Askenase
B Cell-dependent T Cell Responses: IgM Antibodies Are Required to Elicit Contact Sensitivity
J. Exp. Med., November 18, 2002; 196(10): 1277 - 1290.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. D. Kaplan, S. K. O'Neill, T. Koreny, M. Czipri, and A. Finnegan
Development of Inflammation in Proteoglycan-Induced Arthritis Is Dependent on Fc{gamma}R Regulation of the Cytokine/Chemokine Environment
J. Immunol., November 15, 2002; 169(10): 5851 - 5859.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
C. H. Nielsen and R. G. Q. Leslie
Complement's participation in acquired immunity
J. Leukoc. Biol., August 1, 2002; 72(2): 249 - 261.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. A. Hietala, I.-M. Jonsson, A. Tarkowski, S. Kleinau, and M. Pekna
Complement Deficiency Ameliorates Collagen-Induced Arthritis in Mice
J. Immunol., July 1, 2002; 169(1): 454 - 459.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
H. Ji, D. Gauguier, K. Ohmura, A. Gonzalez, V. Duchatelle, P. Danoy, H.-J. Garchon, C. Degott, M. Lathrop, C. Benoist, et al.
Genetic Influences on the End-Stage Effector Phase of Arthritis
J. Exp. Med., August 6, 2001; 194(3): 321 - 330.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.